JP Morgan Chase’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-425,628
| Closed | -$57.1M | – | 6161 |
|
|
2020
Q3 | $57.1M | Buy |
425,628
+153,299
| +56% | +$16.3M | 0.01% | 909 |
|
|
2020
Q2 | $26.3M | Buy |
272,329
+27,763
| +11% | +$2.32M | 0.01% | 1204 |
|
|
2020
Q1 | $11.5M | Buy |
244,566
+37,367
| +18% | +$2.39M | ﹤0.01% | 1632 |
|
|
2019
Q4 | $15.1M | Buy |
207,199
+68,367
| +49% | +$4.15M | ﹤0.01% | 1788 |
|
|
2019
Q3 | $7.24M | Buy |
138,832
+6,687
| +5% | +$356K | ﹤0.01% | 2385 |
|
|
2019
Q2 | $6.38M | Sell |
132,145
-4,191
| -3% | -$204K | ﹤0.01% | 2450 |
|
|
2019
Q1 | $7.09M | Buy |
136,336
+24,341
| +22% | +$1.12M | ﹤0.01% | 2324 |
|
|
2018
Q4 | $5.47M | Buy |
111,995
+82,271
| +277% | +$4.53M | ﹤0.01% | 2504 |
|
|
2018
Q3 | $1.94M | Sell |
29,724
-125,416
| -81% | -$7.38M | ﹤0.01% | 3487 |
|
|
2018
Q2 | $7.7M | Sell |
155,140
-19,155
| -11% | -$927K | ﹤0.01% | 2348 |
|
|
2018
Q1 | $8.51M | Sell |
174,295
-67,350
| -28% | -$3.5M | ﹤0.01% | 2139 |
|
|
2017
Q4 | $10.2M | Buy |
241,645
+78,570
| +48% | +$3.03M | ﹤0.01% | 2110 |
|
|
2017
Q3 | $6.94M | Sell |
163,075
-313,500
| -66% | -$10M | ﹤0.01% | 2297 |
|
|
2017
Q2 | $6.24M | Buy |
476,575
+242,408
| +104% | +$3.19M | ﹤0.01% | 2330 |
|
|
2017
Q1 | $3.08M | Buy |
234,167
+64,017
| +38% | +$820K | ﹤0.01% | 2768 |
|
|
2016
Q4 | $2.2M | Sell |
170,150
-2,100
| -1% | -$32.3K | ﹤0.01% | 3005 |
|
|
2016
Q3 | $2.81M | Sell |
172,250
-178,475
| -51% | -$3.22M | ﹤0.01% | 2594 |
|
|
2016
Q2 | $4.35M | Buy |
350,725
+106,688
| +44% | +$1.33M | ﹤0.01% | 2379 |
|
|
2016
Q1 | $2.61M | Buy |
+244,037
| New | +$2.22M | ﹤0.01% | 2563 |
|
JP Morgan Chase's MYOK Position: Q4 2020 in Review
JP Morgan Chase sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 425,628 shares — an estimated $57.1M sold.
JP Morgan Chase first reported a position in MYOK in Q1 2016 and held it in 19 quarters. The position peaked at $57.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- JP Morgan Chase reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- JP Morgan Chase sold 425,628 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $57.1M.
- JP Morgan Chase first reported a position in MyoKardia, Inc. Common Stock in Q1 2016 and held it in 19 quarters.
- JP Morgan Chase's MyoKardia, Inc. Common Stock position peaked at $57.1M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.